CoChat
Sign Up
Cited by 4Acute Kidney Injury ResearchMolecular Sensors and Ion Detectionbioluminescence and chemiluminescence research

Ultrasensitive chemiluminescent probe activated by NAG for real-time monitoring of AKI

Tan, Liyi, Liang, En, Zheng, Xinhui, Ding, Hanying, Yang, Xiaobing, Chen, Ting, Feng, Xiayu, Cheng, Kui·2025·Bioorganic Chemistry
DOI 10.1016/j.bioorg.2025.108817
Open this paper in CoChat — free account

Abstract

Acute kidney injury (AKI) not only increases the likelihood of developing chronic kidney disease (CKD) but also leads to considerable morbidity and mortality, highlighting the urgent need for early diagnostic tools. Current techniques that depend on serum creatinine (sCr) and blood urea nitrogen (BUN) are not sensitive enough to detect early tubular damage. To overcome this limitation, we created NAG-CL, a chemiluminescent probe activated by N-acetyl-β-D-glucosaminidase (NAG), which serves as a biomarker that rises in the early stages of AKI. The NAG-CL operates through NAG-mediated enzymatic cleavage of the protective moiety, yielding a fluorescent product while concomitantly triggering a robust chemiluminescent emission. It offers superior advantages, including rapid activation (in less than 20 min), an ultra-low detection limit (0.004 U/L) and high selectivity. In vitro studies have confirmed its specificity and sensitivity, surpassing traditional fluorescent probes by 16.4 times in terms of lower limit of detection (LOD). Non-invasive urine tests in mice with cisplatin-induced AKI showed early detection of NAG, which correlated with the progression of renal injury. Significantly, NAG-CL demonstrates a notable ability to distinguish between patients and healthy individuals' urine samples, indicating its potential utility in the diagnosis of kidney injury. This study established NAG-CL as a chemiluminescent probe for realtime, non-invasive monitoring of acute kidney injury (AKI), demonstrating superior performance compared to existing methods, and holds promise as a fast and effective non-invasive diagnostic tool for AKI in clinical settings.

Integrity signals

Registry

Crossref · 10.1016/j.bioorg.2025.108817

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Tan, L., Liang, E., Zheng, X., Ding, H., Yang, X., Chen, T., Feng, X., & Cheng, K.
Affiliations
  • Southern Medical University (CN)
  • Nanfang Hospital (CN)
Corresponding author
Cheng, Kui
ORCID
Venue
Bioorganic Chemistry
Publisher
Elsevier BV
Published
2025-09
Volume
164
Pages
108817
ISSN
0045-2068 (ISSN-L)
DOI
10.1016/j.bioorg.2025.108817
OpenAlex
W4412999847
Cited by
4
References
35
Citations by year
2026: 3 · 2025: 1
FWCI
2.75
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Bioorganic Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Natural Science Foundation of Guangdong Province (2024A1515010642)
  • National Natural Science Foundation of China (82073689, 82273762)
Topics
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Physical Sciences › Chemistry › Spectroscopy › Molecular Sensors and Ion Detection
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › bioluminescence and chemiluminescence research
Keywords
acute kidney injury, chemiluminescent probes, N-acetyl-beta-D-glucosaminidase, early biomarker detection, enzymatic cleavage, cisplatin nephrotoxicity, real-time monitoring, renal tubular injury, low detection limit
MeSH terms
Acetylglucosaminidase, Animals, Cisplatin, Fluorescent Dyes, Humans, Luminescent Measurements, Male, Molecular Structure, Biomarkers, Mice, Limit of Detection, Acute Kidney Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review